Prescribing in pregnancy for women with diabetes: Use of potential teratogenic drugs and contraception

Diabetic Medicine

Volumn 30, Issue 4, 2013, Pages 457-463

  Makda, S I ^a   Davies, Melanie J ^a   Wilmot, E ^a   Bankart, J ^a   Yates, T ^a   Varghese, E M ^b   Fisher, H ^c   Anwar, A ^d   Khunti, K ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL CONTRACEPTIVE AGENT; TERATOGENIC AGENT; CARDIOVASCULAR AGENT; CONTRACEPTIVE AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CHI SQUARE TEST; COHORT ANALYSIS; CONTRACEPTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MICROANGIOPATHY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PRESCRIPTION; RANK SUM TEST; RETINOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STUDENT T TEST; UNITED KINGDOM; UNIVARIATE ANALYSIS; DIABETIC CARDIOMYOPATHY; DRUG CONTRAINDICATION; MIDDLE AGED;

ADOLESCENT; ADULT; CARDIOVASCULAR AGENTS; CONTRACEPTIVE AGENTS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS; TERATOGENS; YOUNG ADULT;

EID: 84883495608     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12051     Document Type: Article

References (26)

1. Hiller T, Pedula K. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001; 24: 1522–1527.
2. Shawe J, Mulnier H, Nicholls P, Lawrenson R. Use of hormonal contraceptive methods by women with diabetes. Prim Care Diabetes 2008; 2: 195–199.
3. Weintrob N, Karp M, Hod M. Short-and long-range complications in offspring of diabetic mothers. J Diabetes Complications 1996; 10: 294–301.
4. CEMACH. Diabetes in Pregnancy: Are We Providing the Best Care? Findings of a National Enquiry: England, Wales and Northern Ireland. London: Confidential Enquiry into Maternal and Child Health, 2007.
5. Conway D, Longer O. Selecting antihypertensive therapy in the pregnant woman with diabetes mellitus. J Matern Fetal Med 2000; 9: 66–69.
6. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease. J Am Med Assoc 1999; 282: 2340–2346.
7. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. Br Med J 2000; 321: 983.
8. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443–2451.
9. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004; 350: 1579–1582.
10. NICE. Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period. 2008. Available at http://publicationsniceorguk/diabetes-in-pregnancy-cg63 Last accessed 31 July 2012.
11. Abalos E, Duley L, Steyn D, Henderson-Smart D. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007; (1): CD002252.
12. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006; 86: 658–663.
13. Hawthorne G. Metformin use and diabetic pregnancy—has its time come? Diabet Med 2006; 23: 223–227.
14. Department of Health. National Service Framework for Diabetes (England) Standards. London: The Stationery Office, 2001.
15. Office of National Statistics. 2001 Census. Available at http://www.statistics.gov.uk Last accessed 31 July 2012.
16. NICE. Type 2 Diabetes: the Management of Type 2 Diabetes. Clinical guideline CG66. London: National Institute for Health and Clinical Excellence, 2008.
17. SPSS Base 7.5 for Windows. User’s Guide Chicago: Statistical Package for the Social Sciences, 1997.
18. Chappell L, Germain S. Controversies in management of diabetes from preconception to the postnatal period. Br Med J 2008; 336: 717–718.
19. Grigoryan OR, Grodnitskaya EE, Andreeva EN, Shestakova MV, Melnichenko GA, Dedov II. Contraception in perimenopausal women with diabetes mellitus. Gynecol Endocrinol 2006; 22: 198– 206.
20. Schwarz EB, Sobota M, Charron-Prochownik D. Perceived access to contraception among adolescents with diabetes. Diabetes Educ 2010; 36: 489–494.
21. Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Womens Health Issues 15: 167– 173.
22. Schwarz EB, Maselli J, Gonzales R. Contraceptive counseling of diabetic women of reproductive age. Obstet Gynecol 2006; 107: 1070–1074.
23. Napoli A, Colatrella A, Botta R, Cianni GD, Fresa R, Gamba S et al. Contraception in diabetic women: an Italian study. Diabetes Res Clin Pract 2005; 67: 267–272.
24. Charron-Prochownik D, Sereika SM, Falsetti D, Wang S-L, Becker D, Jacober S et al. Knowledge, attitudes and behaviors related to sexuality and family planning in adolescent women with and without diabetes. Pediatr Diabetes 2006; 7: 267–273.
25. Pringle M, Ward P, Chilvers C. Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer. Br J Gen Pract 1995; 45: 537–541.
26. Mahmud M, Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations. BMC Womens Health 2010; 10: 5.